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Intermittent Claudication:
An Objective Office-Based Assessment
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OBJECTIVES We sought to compare standard lower extremity vascular laboratory treadmill exercise with
the office-based active pedal plantarflexion technique.
BACKGROUND Intermittent claudication is relatively common in elderly patients and is an important
predictor of cardiovascular morbidity and mortality. Noninvasive testing using resting and
posttreadmill exercise ankle:brachial systolic blood pressure indices is often required to
confirm the diagnosis and objectively assess the severity of lower extremity arterial occlusive
disease. This is traditionally performed in a formal vascular laboratory setting.
METHODS Fifty consecutive patients (100 lower extremities) with known or suspected intermittent
claudication referred for lower extremity treadmill exercise testing were also tested with active
pedal plantarflexion using a prospective, randomized crossover design. Supine ankle:brachial
systolic blood pressure indices were measured immediately before and after each form of
exercise.
RESULTS There was an excellent correlation (r 5 0.95, 95% confidence interval 0.93 to 0.97) between
mean postexercise ankle:brachial systolic blood pressure indices for treadmill exercise and
active pedal plantarflexion. There was no significant difference in outcome based on the order
of testing or the severity of arterial occlusive disease. Symptoms of angina or dyspnea occurred
in 11 patients (22%) with treadmill exercise versus zero patients with active pedal plantar-
flexion.
CONCLUSIONS Active pedal plantarflexion is an office-based test that compares favorably with treadmill
exercise for the noninvasive, safe, objective and economical assessment of lower extremity
arterial occlusive disease. (J Am Coll Cardiol 2001;37:1381–5) © 2001 by the American
College of Cardiology
Intermittent claudication, the hallmark of symptomatic
peripheral arterial occlusive disease (PAOD), is frequently
encountered in clinical practice. With care, the many
musculoskeletal and neurologic conditions that may be
confused with intermittent claudication can often be differ-
entiated by history alone. Palpation of the peripheral pulses
may provide important information about the presence of
PAOD, but peripheral pulses vary with position, edema,
anatomic abnormalities, heart disease, ambient temperature
and other variables. Palpation is also subjective and depen-
dent upon the examiner’s skill and experience. Therefore,
objective testing is often required to establish the diagnosis
of PAOD, assess disease severity and follow its progression.
The ankle:brachial systolic blood pressure index (ABI) is
the most commonly used noninvasive test in the diagnosis
of PAOD. The ABI is defined as the ratio of the ankle
systolic blood pressure (either dorsalis pedis or posterior
tibial artery) to the brachial artery systolic blood pressure. A
normal supine resting ABI is 1.0; with values of 0.8 to 0.9,
0.5 to 0.8, and ,0.5 correlating with mild, moderate and
severe PAOD, respectively. Peripheral arterial occlusive
disease has been found in up to 28% of a population with a
mean age of 66 years and in 58% with a mean age of 81 years
(1,2). Furthermore, an abnormal ABI has been shown to be
an independent predictor of cardiovascular mortality (rela-
tive risk 5 4) and cerebrovascular events (relative risk 5 2)
(3,4). Thus the early recognition of PAOD both alerts the
clinician to a specific disease entity for which effective
treatment exists and provides the opportunity to address
concomitant cardiovascular and cerebrovascular disease.
It is important to recognize that a resting ABI may fail to
detect PAOD or underestimate its severity. Lower extrem-
ity exercise produces a decrease in ABI in the presence of
significant PAOD, greatly enhancing the sensitivity of the
test. Walking on a treadmill is the most commonly used
exercise for this purpose; however, treadmill is not the only
form of exercise that may be used. Active pedal plantarflex-
ion (APP), which involves repeatedly standing up on the
toes, may be a simpler, more cost-effective alternative. It is
important to ascertain the relationship between treadmill
exercise testing and APP with respect to ABI response if we
are to be able to substitute APP. Therefore, the current
study was undertaken to compare traditional treadmill
exercise with APP in patients with known or suspected
PAOD.
METHODS
Subjects. The local institutional committee on human
research approved the protocol. All subjects provided in-
formed consent. Fifty consecutive patients (100 lower ex-
tremities) with suspected intermittent claudication were
studied. All subjects had been referred to the Mayo Clinic
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Vascular Laboratory for assessment of PAOD. Prior expe-
rience had demonstrated that there would be significant
numbers of both normal and abnormal test results in such a
population. If normal is defined as a post-treadmill exercise
ABI .0.90, then there were 34 normal limbs and 66
abnormal limbs in the study. Exclusion criteria included
noncompressible vessels (ankle systolic blood pressure
.300 mm Hg or .50 mm Hg higher than brachial systolic
blood pressure), critical limb ischemia and inability to walk
on a treadmill or perform active pedal plantarflexion.
Testing protocol. A crossover design was used so that all
subjects underwent both treadmill and APP testing. The
schema is illustrated in Figure 1. The order of testing was
randomized. Rest periods of 15 and 30 min were allowed
before and after the first test, respectively. Ankle:brachial
indices were performed immediately before and within the
first minute after each form of exercise. Ankle systolic
blood pressures were obtained using a Doppler stethoscope
(MedaSonics, Minnetonka, Minnesota) with an appropri-
ately sized blood pressure cuff placed just above the ankle.
Blood pressure cuffs were kept consistent throughout the
study. The posterior tibial artery, because it is easier to
locate, was used preferentially over the dorsalis pedis artery
whenever possible. Optimum signal position was marked
with a temporary ink skin dot to facilitate rapid relocation
of the pulse following exercise. The same pedal artery was
used for both tests. If no pedal artery Doppler signal was
detected, the ABI was taken to be zero. Brachial artery
systolic blood pressures were obtained manually using stan-
dard auscultation technique. The higher of the two brachial
artery systolic blood pressures was used to calculate the ABI.
The treadmill protocol consisted of a 5-min walk on a
10% grade at 2 miles per hour (mph). If the subject was
unable to walk at 2 mph, the speed was reduced to 1.5 or
1.0 mph as required. Treadmill exercise was symptom-
limited so that premature termination of exercise was
permitted if the subject was experiencing undue lower
extremity discomfort, angina, dyspnea or significant
arrhythmia.
The APP protocol (Fig. 2), also symptom-limited, con-
sisted of up to 50 consecutive repetitions of active ankle
plantarflexion while standing. The knees were to be kept
fully extended. Subjects were allowed fingertip support
against a wall to assist with balance.
Statistics. The means and standard deviations of the base-
line and post-test ABIs for APP and treadmill testing were
calculated, along with the means and standard deviations of
the paired differences. Paired t tests tested whether the
paired difference means were significantly different from
zero. Pearson correlation coefficients were calculated to
assess the agreement between APP and treadmill mean
ABIs. Subgroups were compared to assess the effects of
order of testing and disease severity. Also, a Bland-Altman
plot, which plots the difference versus the mean of the APP
and treadmill post-test ABIs, was constructed to examine
the difference between the two tests as a function of the level
of ABI in that subject.
Because data on both legs of each subject were pooled for
analysis, the assumption of independence was in question.
Abbreviations and Acronyms
ABI 5 ankle:brachial index
APP 5 active pedal plantarflexion
PAOD 5 peripheral arterial occlusive disease
r 5 Pearson correlation coefficient
SD 5 standard deviation
Figure 1. Schema of study design. ABI 5 ankle:brachial index; APP 5
active pedal plantarflexion.
Figure 2. Active pedal plantarflexion technique. The subject begins stand-
ing flat-footed and raises his heels as high as possible while keeping the
knees straight. He then immediately lowers his heels and repeats the cycle
for up to 50 consecutive repetitions.
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Bootstrap sampling of subjects was performed to assess the
impact of the lack of independence on the standard error of
the mean difference between the two methods. The boot-
strap standard errors were not much different from the
standard errors obtained assuming independence between
limbs of each subject. Consequently, mean and standard
deviations based on the independence assumption are re-
ported.
RESULTS
The 50 subjects consisted of 28 men and 22 women with a
mean age of 71 years (range 52 to 83 years). Subjects
completed a mean of 43 APP repetitions (standard devia-
tion [SD] 5 10) with 30 (60%) completing the full 50
repetitions. Those who stopped prematurely did so because
of lower extremity fatigue or discomfort. Subjects walked a
mean of 3.5 min (SD 5 1.4) or 160 yards (SD 5 88) on the
treadmill, with 20 subjects (40%) completing the full 5-min
protocol.
The mean and standard deviations of the baseline and
post-test ABIs for APP and treadmill testing can be found
in Tables 1 to 3 along with the paired t test p values and
Pearson correlation coefficients (r value) with 95% confi-
dence intervals. Listed are subgroups divided with respect to
order of testing (Table 1), disease severity evident at baseline
(Table 2) and combined results for all subjects (Table 3).
The combined results for all subjects are also graphically
illustrated in Figure 3.
The post-test ABI is the single most important value in
assessing the severity of PAOD; therefore, a Bland-Altman
plot of the difference versus the average for the post-test
ABIs for each individual subject is shown in Figure 4. This
also illustrates the broad range of disease severity studied.
DISCUSSION
In our prospective, randomized crossover study of a consec-
utive series of patients, we found that active pedal plantar-
flexion compared favorably with treadmill exercise for the
noninvasive objective assessment of PAOD.
Two previous small pilot studies have also suggested
significant correlation between these two tests. A study of
five patients (10 limbs) found 100% concordance in imme-
diate post-stress ABIs after both treadmill and APP. The
authors also found an excellent correlation between APP
and postobstructive reactive hyperemia, an uncomfortable,
infrequently used test for PAOD (5). Another study exam-
ined 14 patients (21 limbs) with intermittent claudication
and resting ABIs over 0.8. There was no significant differ-
ence in percent pressure change postexercise between APP
and treadmill exercise (6).
The mean pre- and post-test ABIs for APP and treadmill
exercise in the current study are virtually identical. Neither
order of testing nor baseline ABI significantly affected
outcome (post-test ABI) when comparing the two tests.
The Bland-Altman plot of post-test ABIs showing each
individual subject illustrates some expected scatter. How-
ever, it is important to note the distribution is approximately
equal above and below the zero line. This indicates that
within the population studied, neither test consistently
produced a greater or lesser drop in ABI than the other test.















. 0.8 Baseline 64 1.09 6 0.14 1.07 6 0.12 0.17 0.77 0.016 0.093
(0.65, 0.85)
Post-test 64 0.86 6 0.25 0.86 6 0.27 0.89 0.90 20.0020 0.12
(0.84, 0.94)
# 0.8 Baseline 36 0.68 6 0.13 0.66 6 0.12 0.039 0.80 0.028 0.078
(0.64, 0.89)
Post-test 36 0.32 6 0.22 0.33 6 0.23 0.46 0.87 20.014 0.11
(0.76, 0.93)
ABI 5 ankle:brachial index; APP 5 active pedal plantarflexion; n 5 number of subjects; p 5 statistical significance; r 5 Pearson correlation coefficient with 95% confidence
interval; SD 5 standard deviation.















APP Baseline 50 0.97 6 0.28 0.97 6 0.26 0.67 0.95 0.0069 0.084
(0.91, 0.97)
Post-test 50 0.73 6 0.34 0.75 6 0.35 0.11 0.96 0.022 0.098
(0.93, 0.98)
Treadmill Baseline 50 0.92 6 0.20 0.88 6 0.20 0.0002 0.91 20.048 0.083
(0.85, 0.95)
Post-test 50 0.60 6 0.35 0.59 6 0.36 0.61 0.93 20.0095 0.13
(0.88, 0.96)
ABI 5 ankle:brachial index; APP 5 active pedal plantarflexion; n 5 number of subjects; p 5 statistical significance; r 5 Pearson correlation coefficient with 95% confidence
interval; SD 5 standard deviation.
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The variability of the ABI must be considered when
interpreting these tests. A mean range in a series of daily
ABI measurements of 0.18 (SD 5 0.07) has been reported
in a group of 35 clinically stable claudicants (7). Testing
found 95% confidence intervals of 616% for single mea-
surements of ABI in a sample of 24 patients with PAOD
and 12 normal subjects (8). Given these data, it would seem
reasonable not to consider a difference in ABI significant
unless it is greater than 0.10 to 0.15. When viewed in this
light of “clinical” (vs. statistical) significance, the already
excellent correlation between APP and treadmill exercise is
further strengthened. Although there are several p values
,0.05 in Tables 1 to 3 for differences in mean baseline ABI
that meet the definition of statistical significance, they
represent such small differences in ABI that they fall far
short of clinical significance.
Our experience with APP has left us enthusiastic with
respect to its potential clinical utility. The complete APP
test can be performed in ,10 min and requires only BP cuffs
and a hand-held Doppler probe. No specialized vascular
laboratory or testing facility is required. Cardiac monitoring
is not required, nor is it necessary to have a physician in
attendance. It was much simpler for patients to perform
APP testing than treadmill testing. Active pedal plantar-
flexion was well tolerated by patients who almost uniformly
reported it as being preferred to the treadmill. No subjects
had symptoms suggestive of myocardial ischemia during
APP, as opposed to nine patients who developed dyspnea
and two patients who developed angina on the treadmill. Of
those 11 subjects with treadmill-induced symptoms, three
had definite cardiac ischemia on their treadmill electrocar-
diograms. We recognize that the assessment of coronary
artery disease may be a secondary advantage of treadmill
testing for lower extremity ischemia; however, the workload
achieved during most PAOD treadmill protocols is inade-
quate for proper assessment of coronary artery disease.
Furthermore, PAOD patients often require pharmacologic
cardiac stress testing because claudication prevents them
from exercising to an adequate workload.
The potential cost savings of APP versus treadmill
exercise are significant. The 1999 Medicare fee for a
peripheral vascular study with exercise and monitoring was
$132.88. This is in contrast to the fee of $65.10 for a
peripheral vascular circulation study of two extremities
without exercise or monitoring (9). An APP fee set midway
between these two fees could represent cost savings of
approximately 25%, assuming that testing is performed in
properly accredited facilities by competent personnel.
Another less obvious advantage of APP testing is the
identification of patients at increased risk for adverse car-
diovascular or cerebrovascular events. An abnormal ABI
identifies patients at increased risk. The National Choles-
terol Education Program recommends a goal low-density
lipoprotein cholesterol level #100 mg/dL for patients with
atherosclerosis (10). Patients with PAOD fall into this
category. This is perhaps especially relevant in light of the
recently recognized benefits of “statin” drugs in the preven-
tion of myocardial infarction, stroke and death in this high
risk population (11–15).
Study limitations. Both our study and the APP technique
have limitations. Orthopedic conditions of the ankle or foot
Figure 3. Mean baseline and post-test ABIs 6 1 standard deviation for all
subjects’ APP and treadmill exercise results. ABI 5 ankle:brachial index;
APP 5 active pedal plantarflexion.
Figure 4. Bland-Altman plot of post-test ABIs for APP and treadmill
exercise testing. The reference lines drawn at 60.15 on the y-axis represent
what might be considered reasonable guidelines for clinically significant
differences in ABI (see text). Abbreviations as in Figure 3.










Baseline 100 0.94 6 0.24 0.92 6 0.24 0.023 0.93 20.021 0.088
(0.90, 0.95)
Post-test 100 0.66 6 0.35 0.67 6 0.36 0.58 0.95 0.0064 0.12
(0.93, 0.97)
ABI 5 ankle:brachial index; APP 5 active pedal plantarflexion; n 5 number of subjects; p 5 statistical significance; r 5 Pearson correlation coefficient with 95% confidence
interval; SD 5 standard deviation.
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may preclude adequate pedal plantarflexion, but still allow
treadmill testing. The variability of the ABI may complicate
interpretation of results. Doppler signals from the pedal
arteries can be difficult to locate and detect, especially in the
presence of severe PAOD. For example, a signal that is
absent immediately after exercise and takes 1 min to
reappear can be difficult to differentiate from a faint signal
that is always present but takes 1 min to find. Therefore,
operator skill and experience become potential confounding
variables.
Active pedal plantarflexion does not incorporate either
segmental pressures or pulse volume recording and is thus
unable to localize the level of arterial occlusive disease.
Patient cooperation is always a concern when subjects have
to push themselves to perform an exercise test. One patient
in our study actually managed to raise his heels by flexing his
knees, instead of using his gastrosoleus muscles, thereby
producing post-test ABIs of dubious validity.
One of the advantages of treadmill exercise is that
provoking lower extremity pain may aid in establishing the
diagnosis, such as differentiating vascular claudication from
neurogenic claudication. Active pedal plantarflexion gener-
ally does not reproduce the lower extremity symptoms
brought on by walking. However, a normal ABI following
APP should exclude significant PAOD as a cause of lower
extremity discomfort.
Conclusions. We conclude that APP is a safe, simple,
accurate, portable and inexpensive bedside test for the
noninvasive objective assessment of patients with known or
suspected PAOD. We recommend APP as an extension of
the physical examination for patients at risk for PAOD, and
potentially as a tool for following those with established
disease.
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